Director/PDMR Shareholding

By

Regulatory News | 16 Nov, 2018

Updated : 15:53

RNS Number : 6704H
InnovaDerma PLC
16 November 2018
 

LEI: 213800WRAP6W8VDL6B38

 

InnovaDerma PLC

 ("InnovaDerma" or the "Company")

InnovaDerma PLC

Director/PDMR Shareholding

Transfer of Shares

InnovaDerma (LSE: IDP), a UK developer of life sciences, beauty and personal care products, has been advised that Cygenta Capital & Advisory Pty Ltd, a company controlled by Joseph Bayer, the Executive Director of the Company, has on 16 November 2018 transferred 7,200 ordinary shares of €0.10 each ("Ordinary Shares") at a price of €nil to Joseph Bayer personally (the "Transfer"). 

The Company also announces, it was notified on 16 November 2018 that Joseph Bayer, has purchased 3,100 Ordinary Shares at a price of 84.5 pence per Ordinary Share (the "Purchase"). 

Following the Purchase, Joseph Bayer personally now holds a total of 23,180 shares.  He also has a separate holding of 93,333 Ordinary Shares held via his Australian Superannuation Fund which Mr Bayer controls. Therefore, Joseph Bayer's total interest in the Company through direct and indirect holdings is 116,513 Ordinary Shares representing approximately 0.8% of the issued share capital of the Company.

This announcement contains inside information for the purposes of Article 7 of EU Regulation 596/2014.

Further enquiries

InnovaDerma

Haris Chaudhry/Joe Bayer

 

+61 (0)3 9863 8030

finnCap Ltd

Geoff Nash/Giles Rolls/Kate Bannatyne

Alice Lane - Corporate Broking

 

+44 (0)207 220 0500

www.finncap.com

TB Cardew

Shan Shan Willenbrock/Tom Allison

Joe McGregor

 

+ 44 (0)20 7930 0777

innovaDerma@tbcardew.com

 

 

 

1.               

Details of the person discharging managerial responsibilities / person closely associated

a)

Name

 Joseph Bayer

 

2.               

Reason for the Notification

 

a)

Position/status

Executive Director

 

b)

Initial notification/Amendment

Initial notification

3.    

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

 

a)

Name

InnovaDerma PLC

 

b)

LEI

213800WRAP6W8VDL6B38

 

4.    

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

 

a)

Description of the Financial instrument, type of instrument

€0.10 each ("Ordinary Shares")

Identification code

IDP         GB00BT9PTW34

 

b)

Nature of the transaction

Purchase of Ordinary Shares

 

c)

Price(s) and volume(s)

Volume and Price - 3,100 Ordinary Shares at 84.5 pence

 

d)

Aggregated information:

Aggregated volume

Price

 

See 4c) above

 

e)

Date of the transaction

16 November 2018

 

f)

Place of the transaction

London Stock Exchange, Main Market

 

 

 

 


This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
DSHUNVVRWRAAAAA

Last news